Skip to main content
The BMJ logoLink to The BMJ
. 1993 Jan 23;306(6872):248. doi: 10.1136/bmj.306.6872.248

Serotonin syndrome caused by a moclobemide-clomipramine interaction.

O Spigset 1, T Mjörndal 1, O Lövheim 1
PMCID: PMC1676747  PMID: 8443525

Full text

PDF

Page 248

248

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balant-Gorgia A. E., Gex-Fabry M., Balant L. P. Clinical pharmacokinetics of clomipramine. Clin Pharmacokinet. 1991 Jun;20(6):447–462. doi: 10.2165/00003088-199120060-00002. [DOI] [PubMed] [Google Scholar]
  2. Rainer C., Scheinost N. A., Lefeber E. J. Neuroleptic malignant syndrome. When levodopa withdrawal is the cause. Postgrad Med. 1991 Apr;89(5):175-8, 180. doi: 10.1080/00325481.1991.11700900. [DOI] [PubMed] [Google Scholar]
  3. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991 Jun;148(6):705–713. doi: 10.1176/ajp.148.6.705. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES